Source: International Congress 2014 – ILDs 5
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Vancheri, F. Drakopanagiotakis, P. Bonniaud, B. Crestani, A. Guenther, A. Wells (Giessen, Germany; Catania, Italy; Dijon, Paris, France; London, United Kingdom). Self-reported sleep quality in IPF. Eur Respir J 2014; 44: Suppl. 58, 3768

Member's Comments

No comment yet.

Related content which might interest you: Sleep quality among patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry Source: International Congress 2014 – ILDs 1 Year: 2014 LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study Source: International Congress 2014 – IPF and surroundings Year: 2014 Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort Source: International Congress 2014 – ILDs 4 Year: 2014 Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Sleep desaturation and pulmonary hypertension determine sleep-related quality of life and depression in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 4 Year: 2014 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014 6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations Source: International Congress 2014 – ILDs 6 Year: 2014 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Reduction in disease progression with nintedanib in the INPULSIS™ trials Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Live patient and partner survey on pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Cognitive failure in sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Prevalence of Obstructive Sleep Apnea in Idiopathic Pulmonary fibrosis Source: International Congress 2018 – Obesity: comorbidities Year: 2018 Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO Source: International Congress 2014 – ILDs 6 Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Cognitive impairment in patients with Idiopathic Pulmonary Fibrosis - Obstructive Sleep Apnea Overlap Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019